153 related articles for article (PubMed ID: 31096309)
41. Venous thromboembolism in cirrhosis: a review of the literature.
Buresi M; Hull R; Coffin CS
Can J Gastroenterol; 2012 Dec; 26(12):905-8. PubMed ID: 23248793
[TBL] [Abstract][Full Text] [Related]
42. Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials.
Joseph P; Glynn R; Lonn E; Ramasundarahettige C; Eikelboom J; MacFadyen J; Ridker P; Yusuf S
Cardiovasc Res; 2022 Feb; 118(3):897-903. PubMed ID: 33705531
[TBL] [Abstract][Full Text] [Related]
43. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
44. Statins Effects on Blood Clotting: A Review.
Siniscalchi C; Basaglia M; Riva M; Meschi M; Meschi T; Castaldo G; Di Micco P
Cells; 2023 Nov; 12(23):. PubMed ID: 38067146
[TBL] [Abstract][Full Text] [Related]
45. Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
Skajaa N; Nagy D; Troelsen FS; Farkas DK; Sørensen HT
Thromb Res; 2021 May; 201():1-5. PubMed ID: 33621859
[TBL] [Abstract][Full Text] [Related]
46. Statin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort study.
Kronenberg RM; Beglinger S; Stalder O; Méan M; Limacher A; Beer JH; Aujesky D; Rodondi N; Feller M
Sci Rep; 2019 Oct; 9(1):14804. PubMed ID: 31616014
[TBL] [Abstract][Full Text] [Related]
47. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.
Boone BA; Murthy P; Miller-Ocuin J; Doerfler WR; Ellis JT; Liang X; Ross MA; Wallace CT; Sperry JL; Lotze MT; Neal MD; Zeh HJ
BMC Cancer; 2018 Jun; 18(1):678. PubMed ID: 29929491
[TBL] [Abstract][Full Text] [Related]
48. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism.
Wang TF; Waller AP; Lin E; Wei L; Bartosic A; Riedl K; Kerlin BA
Blood Coagul Fibrinolysis; 2021 Jan; 32(1):16-22. PubMed ID: 33196511
[TBL] [Abstract][Full Text] [Related]
49. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
[TBL] [Abstract][Full Text] [Related]
50. Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.
Alirezaei T; Sattari H; Irilouzadian R
Clin Cardiol; 2022 Jul; 45(7):717-722. PubMed ID: 35481712
[TBL] [Abstract][Full Text] [Related]
51. Dose-related effect of statins in venous thrombosis risk reduction.
Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
[TBL] [Abstract][Full Text] [Related]
52. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
[TBL] [Abstract][Full Text] [Related]
53. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
Chunilal SD; Bates SM
Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
[TBL] [Abstract][Full Text] [Related]
54. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
55. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment.
Ray JG
Curr Opin Pulm Med; 2003 Sep; 9(5):378-84. PubMed ID: 12904707
[TBL] [Abstract][Full Text] [Related]
56. [Drugs and venous thromboembolism].
Lacut K; Mottier D; Pottier P
Rev Pneumol Clin; 2008 Dec; 64(6):290-7. PubMed ID: 19084208
[TBL] [Abstract][Full Text] [Related]
57. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
58. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial.
Jung YJ; Seo HS; Park CH; Jeon HM; Kim JI; Yim HW; Song KY
JAMA Surg; 2018 Oct; 153(10):939-946. PubMed ID: 30027281
[TBL] [Abstract][Full Text] [Related]
59. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
60. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
